Drug Pipeline

barzolvolimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
1
Recruiting
4
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT07256392
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With…
overall status: "Recruiting" → "Enrolling By Invitation"
2026-05-27 NCT07256392
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With…
Trial sites expanded: 20 -> 34 locations
Active Studies by Phase
Phase 3
4
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07266402 A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo… Chronic Inducible Urticaria Recruiting
NCT06445023 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Chronic Spontaneous Urticaria Active, Not Recruiting
NCT06455202 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) Chronic Spontaneous Urticaria Active, Not Recruiting
NCT07256392 Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With… Chronic Spontaneous Urticaria Enrolling by Invitation
Phase 2
NCT06366750 A Study of Barzolvolimab in Patients With Prurigo Nodularis Prurigo Nodularis Active, Not Recruiting
NCT06727552 A Study of Barzolvolimab in Patients With Atopic Dermatitis Atopic Dermatitis Active, Not Recruiting
Sponsors Running barzolvolimab Trials
Disease Areas
Get alerts when barzolvolimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free